Zeitschriftenaufsatz
|
1999
Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II study.
Autor:in
Löhr, M; Bago, Z T; Bergmeister, H; Ceijna, M; Freund, M; Gelbmann, W; Günzburg, W H; Jesnowski, R; Hain, J; Hauenstein, K; Henninger, W; Hoffmeyer, A; Karle, P; Kröger, J C; Kundt, G; Liebe, S; Losert, U; Müller, P; Probst, A; Püschel, K; Renner, M; Renz, R; Saller, R; Salmons, B; Walter, I;
Publikationen als Autor:in / Herausgeber:in der Vetmeduni
Journal
Schlagwörter
Adult; Aged; Cell Line; Cytochrome P-450 CYP2B1/administration & dosage*; Cytochrome P-450 CYP2B1/genetics*; Drug Compounding*; Female; Genetic Therapy*; Genetic Vectors; Humans; Ifosfamide/administration & dosage; Ifosfamide/pharmacology*; Male; Middle Aged; Pancreatic Neoplasms/therapy*; Transfection*;
Dokumententyp
Originalarbeit
ISSN/eISSN
0946-2716 -
10.1007/s001090050366
WoS ID
PubMed ID